Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/tid.13417 http://scihub22266oqcxt.onion/10.1111/tid.13417 32666588!7404415!32666588     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Transpl+Infect+Dis 2021 ; 23 (1): e13417 Nephropedia Template TP {{tp|p=32666588|t=2021. COVID-19, liver transplant, and immunosuppression: Allies or foes?|pdf=|usr=}}{{32666588}} gab.com Text COVID-19, liver transplant, and immunosuppression: Allies or foes JO: Transpl Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32666588 #FOAvip Liver transplant (LT) recipients are considered at a particularly high risk for developing critical COVID-19 infection. To date, available data are heterogeneous and scarce and mortality in LT recipients seems to be higher compared to normal population, but whether this is caused by altered immunological status, immunosuppression (IS), or underlying comorbidities has not yet been fully clarified. Some evidences show that IS might play a role in the pathophysiology of this new disease. We searched all available data regarding LT recipients infected by COVID-19, focusing on the role of IS. To date, 244 LT recipients have been reported as COVID-19-positive. Trends among transplant physicians are to reduce overall IS, especially antimetabolite drugs, but the current available observations are still not enough to build strong evidences for recommendation and IS should be meticulously tailored case by case. Twit Text FOAVip COVID-19, liver transplant, and immunosuppression: Allies or foes ????Transpl Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32666588 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32666588 #FOAvip English Wikipedia <ref>{{Cite pmid|32666588}}</ref> COVID-19, liver transplant, and immunosuppression: Allies or foes? #MMPMID32666588 Parente A; Manzia TM; Angelico R; Tirotta F; Muiesan P; Tisone G; Framarino Dei Malatesta M Transpl Infect Dis 2021[Feb]; 23 (1): e13417 PMID32666588show ga Liver transplant (LT) recipients are considered at a particularly high risk for developing critical COVID-19 infection. To date, available data are heterogeneous and scarce and mortality in LT recipients seems to be higher compared to normal population, but whether this is caused by altered immunological status, immunosuppression (IS), or underlying comorbidities has not yet been fully clarified. Some evidences show that IS might play a role in the pathophysiology of this new disease. We searched all available data regarding LT recipients infected by COVID-19, focusing on the role of IS. To date, 244 LT recipients have been reported as COVID-19-positive. Trends among transplant physicians are to reduce overall IS, especially antimetabolite drugs, but the current available observations are still not enough to build strong evidences for recommendation and IS should be meticulously tailored case by case. |*Immunocompromised Host[MESH] |*Liver Transplantation[MESH] |*SARS-CoV-2[MESH] |*Transplant Recipients[MESH] |Adolescent[MESH] |Adult[MESH] |COVID-19/*pathology[MESH] |Child[MESH] |Female[MESH] |Graft Rejection[MESH] |Humans[MESH] |Immunosuppressive Agents/*administration & dosage/therapeutic use[MESH] |Male[MESH] |Middle Aged[MESH]COVID-19, liver transplant, and immunosuppression: Allies or foes?(epmc).pdf DeepDyve Pubget Overpricing